- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.08. | Psyence Group Inc (2): Psyence Group enters LOI to acquire GoldCoast | 3 | Stockwatch | ||
| 22.08. | XFRA EKW0: WIEDERAUFNAHME/RESUMPTION | 347 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 22.08. | Psyence Group Inc. Enters Into a Letter of Intent to Acquire Goldcoast Resource Corp. | 367 | ACCESS Newswire | TORONTO, ON / ACCESS Newswire / August 22, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), announces that it has entered into a letter of intent (the "LOI") to acquire all of the... ► Artikel lesen | |
| 08.07. | Psyence Group Inc (2): Psyence closes $124,000 second tranche of placement | 1 | Stockwatch | ||
| 07.07. | Psyence Group Inc. Closes Second Tranche of Non-Brokered Private Placement for Remaining Proceeds | 413 | ACCESS Newswire | TORONTO, ON / ACCESS Newswire / July 7, 2025 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), is pleased to announce that it has successfully closed the second tranche ("Tranche 2") of... ► Artikel lesen | |
| PSYENCE GROUP Aktie jetzt für 0€ handeln | |||||
| 26.06. | Psyence Group Inc (2): Psyence closes $476,000 first tranche of financing | 1 | Stockwatch | ||
| 25.06. | PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares | 1 | GlobeNewswire (USA) | ||
| 19.06. | Psyence Group Inc (2): Psyence Group arranges $600,000 private placement | 1 | Stockwatch | ||
| 18.06. | Psyence Group announces offering of up to C$600,000 non-brokered private placement of common shares | 1 | Seeking Alpha | ||
| 18.06. | PSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common Shares | 1 | GlobeNewswire (USA) | ||
| 23.04. | XFRA 8VC0,BC21,EKW0,1S90: AUSSETZUNG/SUSPENSION | 202 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILGREAT PLAINS MET.... ► Artikel lesen | |
| 23.04. | XFRA NEW INSTRUMENTS AVAILABLE ON 23.04.2025 | 405 | Xetra Newsboard | The following instruments on XETRA do have their first trading 23.04.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.04.2025
Aktien
1 US7866231084 AB Sagax ADR
2 US36170Y1038... ► Artikel lesen | |
| 22.04. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.04.2025 | 475 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 22.04.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.04.2025ISIN NameCA00833F3079 AFRICAN... ► Artikel lesen | |
| 22.04. | XFRA ISIN CHANGE | 482 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA00833F3079 African Energy Metals Inc. 22.04.2025 CA5589221004 Magma Silver Corp. 23.04.2025 Tausch 1:1CA74449Q1063 Psyence... ► Artikel lesen | |
| 22.04. | CSE Bulletin: Consolidation - Psyence Group Inc. (PSYG) | 389 | Newsfile | Toronto, Ontario--(Newsfile Corp. - Le 21 avril/April 2025) - Psyence Group Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated... ► Artikel lesen | |
| 21.04. | Psyence Group Inc: Psyence Group 1:15 rollback | 2 | Stockwatch | ||
| 17.04. | Psyence Group Inc.: Psyence Group Announces Share Consolidation | 208 | GlobeNewswire (Europe) | TORONTO, April 17, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc. ("Psyence Group" or the "Company") (CSE: PSYG), announces that the Company will be consolidating all of its issued and outstanding share... ► Artikel lesen | |
| 09.04. | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 09.04.2025 | 1.018 | Xetra Newsboard | The following instruments on XETRA do have their first trading 09.04.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 09.04.2025
Aktien
1 US83192D4025 Smartstop Self Storage... ► Artikel lesen | |
| 10.03. | Psyence Group Inc.: Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, names Albert P. Garcia-Romeu, Ph.D. as Chair of its Newly Created Scientific Advisory Board | 233 | GlobeNewswire (Europe) | TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc ("Psyence Group" or the "Company") (CSE: PSYG) is pleased that its NASDAQ-listed associate, Psyence Biomedical Ltd (NASDAQ: PBM) ("PBM"... ► Artikel lesen | |
| 31.10.24 | Psyence Group Inc.: Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs | 207 | GlobeNewswire (Europe) | PsyLabs develops and produces certified pharmaceutical-grade nature-derived psychedelics for applications in mental health and well-being Psyence Biomedical has issued common shares to Psyence... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 41,225 | +1,41 % | QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast | QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the third quarter of 2025.
Press release date time: Tuesday, November 4, shortly after 22:05... ► Artikel lesen | |
| PRAXIS PRECISION MEDICINES | 162,59 | 0,00 % | Praxis Precision Medicines prices $525M public offering | ||
| AVIDITY BIOSCIENCES | 48,780 | -3,39 % | Avidity Biosciences, Inc.: Avidity Biosciences Announces Positive Pre-BLA Meeting with U.S. FDA for del-zota in DMD44 with a Submission Planned for Q1 2026 | SAN DIEGO, Oct. 13, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics... ► Artikel lesen | |
| MINERALYS THERAPEUTICS | 42,970 | -0,85 % | Mineralys Therapeutics: Aktie erreicht Rekordhoch von 41,11 USD | ||
| RECURSION PHARMACEUTICALS | 6,360 | 0,00 % | Recursion Pharmaceuticals (RXRX) Extends Gains, Jumps 15.28% on Major AI Event | ||
| ADMA BIOLOGICS | 14,560 | 0,00 % | ADMA Biologics, Inc.: ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update | 2Q 2025 Total Revenue of $122.0 Million, a 14% YoY Increase, and a 29% YoY Increase Excluding a Prior Year Non-Recurring Item 2Q 2025 GAAP Net Income of $34.2 Million, a 7% YoY Increase 2Q 2025 Adjusted... ► Artikel lesen | |
| CG ONCOLOGY | 41,850 | -2,72 % | CG Oncology Inc.: CG Oncology Completes Enrollment in PIVOT-006 | - Rapid enrollment underscores high unmet need in intermediate-risk non-muscle invasive bladder cancer (NMIBC) -- One of the largest randomized phase 3 studies in this patient population will encompass... ► Artikel lesen | |
| ARCUTIS BIOTHERAPEUTICS | 20,910 | 0,00 % | Arcutis Biotherapeutics, Inc.: FDA Approves Arcutis' ZORYVE (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5 | ZORYVE cream 0.05% provides rapid and effective relief of mild to moderate atopic dermatitis in children ages 2 to 5 and is safe and well toleratedOnce-daily, steroid-free cream can be used anywhere... ► Artikel lesen | |
| EVOTEC | 6,876 | +2,20 % | Rheinmetall Aktie: Nächstes Kursziel - Aixtron, Evotec, Gerresheimer, Ottobock und Valneva im Marktbericht Börse Frankfurt | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 21,990 | 0,00 % | Summit Therapeutics to Host ESMO Data Update & Third Quarter Earnings Call on October 20, 2025 | Conference Call to be Held at 8:00am ET
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") will host an ESMO Data Update and Third Quarter Earnings Call on Monday, October... ► Artikel lesen | |
| ARS PHARMACEUTICALS | 10,110 | 0,00 % | ARS Pharmaceuticals, Inc.: ARS Pharmaceuticals Receives Favorable Decision from European Patent Office on Patent Related to neffy (epinephrine nasal spray) | SAN DIEGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial-stage biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to... ► Artikel lesen | |
| QUANTUM-SI | 2,535 | 0,00 % | Cathie Wood's ARK buys Genedx, sells Quantum-Si stock | ||
| DAY ONE BIOPHARMACEUTICALS | 7,470 | -3,92 % | Day One Biopharmaceuticals, Inc. - 8-K, Current Report | ||
| SANA BIOTECHNOLOGY | 5,305 | 0,00 % | Sana Biotech surges as Eric Jackson calls it a 100-bagger | ||
| JANUX THERAPEUTICS | 27,200 | -3,85 % | Janux Therapeutics: Günstige Gelegenheit | Janux Therapeutics hat mit seiner innovativen Plattformtechnologie im letzten Jahr das Interesse vieler Investoren geweckt - nicht zuletzt aufgrund von Übernahmegerüchten. Doch unabhängig von einem... ► Artikel lesen |
Das Unternehmen PSYENCE GROUP INC kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,063 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PSYENCE GROUP INC finden Sie auf Wallstreet Online.